NEUROLOGIC MANIFESTATIONS ASSOCIATED WITH COVID-19 IN PEDIATRIC PATIENTS AT DR. KARIADI HOSPITAL SEMARANG

Authors

  • Tun Paksi Sareharto Department of Child Health, Faculty of Medicine Universitas Diponegoro-Kariadi Hospital, Semarang, Indonesia, Indonesia
  • Dania Emeralda Firdausy Faculty of Medicine Universitas Diponegoro, Semarang, Indonesia, Indonesia https://orcid.org/0000-0001-8056-7055
  • Santoso Jaeri Department of Medical Biology and Biochemistry, Faculty of Medicine Universitas Diponegoro, Semarang, Indonesia , Indonesia https://orcid.org/0000-0002-0664-0039
  • Alifiani Hikmah Putranti Department of Child Health, Faculty of Medicine Universitas Diponegoro-Kariadi Hospital, Semarang, Indonesia , Indonesia

DOI:

https://doi.org/10.21460/bikdw.v9i2.840

Keywords:

Children, COVID-19, MIS-C, Neurology

Abstract

Background: Coronavirus Disease-19 (COVID-19), a severe acute respiratory syndrome,  stems from a novel coronavirus known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The common symptoms and signs of COVID-19 are fever, cough, diarrhea, and myalgia as well as neurological manifestations. Neurological manifestations of COVID-19 in adult patients have been well recognized, unfortunately, there is limited evidence of neurological manifestations of COVID-19 in children, especially in Indonesia, so herewith we describe neurological manifestations in children, to contribute to the knowledge in the fields of pediatric health and neurology, particularly their correlation with COVID-19. Objective: To determine the neurological manifestations in children with COVID-19. Method: An observational analytic study among 124 pediatric patients with COVID-19 at Dr. Kariadi Hospital Semarang. Demographic and clinical data were obtained from medical records. To determine risk factors for the occurrence of neurological manifestation, the chi-square test, Fisher exact test, and Mann-Whitney U-test were performed. Results: Out of 124 subjects, 49 (39.5%) developed neurological manifestations, including headache (10%), seizure (23%), weakness (5%), dizziness (0.8%), vision impairment (0.8%), ataxia (0.8%), coma (11.3%), paresthesia (0.8%), acute encephalopathy (3.2%), sympathetic storming (0.8%), and others (9.7%). Diagnosis of Multisystem Inflammatory Syndrome in Children (MIS-C) was found in 10 (8.1%) patients, in addition, there was a significant association between the diagnosis of MIS-C, comorbid conditions, and outcomes among patients and neurological manifestations. Conclusion: The most common neurological manifestation experienced by pediatric patients with COVID-19 in this study was seizures. Patients with MIS-C and pre-existing conditions are at higher risk of experiencing neurological manifestations. Children with neurological manifestations more frequently presented with worse outcomes.

References

Shi Y, Wang G, Cai X peng, Deng J wen, Zheng L, Zhu H hong et al. An overview of COVID-19. J Zhejiang Univ B. 21(5):343–.

Ahmad FB, Cisewski JA, Miniño A AR. Provisional Mortality Data — United States, 2020. MMWR Morbidity and Mortality Weekly Report. 70(14):519–22.

Zhu F AJ. COVID-19 Infection in Children: Diagnosis and Management. Curr Infect Dis Rep. 2022;24(4):51–62.

Zimmermann P CN. Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355–68.

Chou SH, Beghi E, Helbok R et al. GCS-NeuroCOVID Consortium and ENERGY Consortium. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open. 2021;4.

Iadecola C., Anrather J. KH. Effects of COVID-19 on the nervous system. Cell. 2020;183(1):16–27.

Ahmad I. RF. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. 2020;77:8–12.

Harapan BN YH. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021;268(9):71.

Ray STJ, Abdel-Mannan O, Sa M, Fuller C, Wood GK, Pysden K et al. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: A prospective national cohort study. Lancet Child Adolesc Heal. 5(9):631–41.

Riva, A.; Piccolo, G.; Balletti, F.; Binelli, M.; Brolatti, N.; Verrotti, A.; Amadori, E.; Spalice, A.; Giacomini, T.; Mancardi MM. et al. Acute Neurological Presentation in Children with SARS-CoV-2 Infection. Front Pediatr. 2022;10.

Fink, E.L.; Robertson, C.L.; Wainwright, M.S.; Roa, J.D.; Lovett, M.E.; Stulce, C.; Yacoub, M.; Potera, R.M.; Zivick E., Holloway A. et al. Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C. Pediatr Neurol. 2021;128:33–44.

Siddique, R.; Khan, S.; Shabana; Li, M.; Xue, M.; Ghanim, K.; Kaimkhani, Z.A.; Mahboob S. Neurological complications of COVID-19 in children and the associated immunological responses. J King Saud Univ Sci. 2022;34.

Al-Ramadan, A.; Rabab’H, O.; Shah, J.; Gharaibeh A. Acute and Post-Acute Neurological Complications of COVID-19. Neurol Int. 2021;13:102–19.

Soltani S, Tabibzadeh A, Zakeri A et al. COVID-19 associated central nervous system manifestations, mental and neurological symptoms: a systematic review and meta-analysis. Rev Neurosci. 2021;32:351–61.

Nejad JH, Allahyari F, Hosseinzadeh R et al. Neurological symptoms of COVID-19 infection; a cross-sectional study on hospitalized COVID-19 patients in Iran. Clin Neurol Neurosurg. 2021;

Dilber B, Ayd?n ZGG, Ye?ilba? O et al. Neurological manifestations of pediatric acute COVID infections: a single center experience. J Trop Pediatr. 2021;67.

Misra S, Kolappa K, Prasad M et al. Frequency of neurologic manifestations in covid-19: a systematic review and meta-analysis. Neurology. 2021;97.

Pascarella A, Maglione M, Lenta S, Sciorio E, Mancusi R, Tucci C, et al. Seizures in Children with SARS-CoV-2 Infection?: Epidemiological, Clinical and Neurophysiological Characterization. 2022;1–9.

Panda PK, Sharawat IK, Panda P et al. Neurogical complications of SARS- CoV-2 infection in children: a systematic review and meta-analysis. J Trop Pediatr. 2020;10.

Schober ME, Robertson CL, Wainwright MS et al. COVID-19 and the pediatric nervous system: global collaboration to meet a global need. Neurocrit Care. 2021;35:283–90.

Hegazi MA, Saeedi FA, Atwah AF, Sayed MH, Albeladi AA, Alyoubi SB, et al. Neurological Manifestations in Pediatric COVID-19 Patients Hospitalized at King Abdulaziz University Hospital, Jeddah, Saudi Arabia: A Retrospective Study. Children. 2022;9(12).

Abbati G, Attaianese F, Rosati A, Indolfi G, Trapani S. Neurological Involvement in Children with COVID-19 and MIS-C: A Retrospective Study Conducted for More than Two Years in a Pediatric Hospital. Children. 2022;9(12).

Frankl S, Coffin SE, HarrisonJB, SwamiSK M. Influenza-associated neurologic complications in hospitalized children. J Pediatr. 2021;239:24–31.

Siracusa, L.; Cascio, A.; Giordano, S.; Medaglia, A.A.; Restivo, G.A.; Pirrone, I.; Saia, G.F.; Collura, F.; Colomba C. Neurological complications in pediatric patients with SARS-CoV-2 infection: A systematic review of the literature. Ital J Pediatr. 2021;47:123

Downloads

Published

2024-12-30

Citation Check